136 related articles for article (PubMed ID: 15485485)
1. Functional importance of the C-terminus of the human norepinephrine transporter.
Distelmaier F; Wiedemann P; Brüss M; Bönisch H
J Neurochem; 2004 Nov; 91(3):537-46. PubMed ID: 15485485
[TBL] [Abstract][Full Text] [Related]
2. Amino acids involved in differences in the pharmacological profiles of the rat and human noradrenaline transporters.
Paczkowski FA; Bryan-Lluka LJ
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):312-7. PubMed ID: 11919656
[TBL] [Abstract][Full Text] [Related]
3. C-terminal region regulates the functional expression of human noradrenaline transporter splice variants.
Sogawa C; Kumagai K; Sogawa N; Morita K; Dohi T; Kitayama S
Biochem J; 2007 Jan; 401(1):185-95. PubMed ID: 16965261
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological properties of the naturally occurring Ala(457)Pro variant of the human norepinephrine transporter.
Paczkowski FA; Bönisch H; Bryan-Lluka LJ
Pharmacogenetics; 2002 Mar; 12(2):165-73. PubMed ID: 11875370
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of the splicing variants of human norepinephrine transporter.
Kitayama S; Morita K; Dohi T
Neurosci Lett; 2001 Oct; 312(2):108-12. PubMed ID: 11595346
[TBL] [Abstract][Full Text] [Related]
6. Roles of transmembrane domain 2 and the first intracellular loop in human noradrenaline transporter function: pharmacological and SCAM analysis.
Sucic S; Bryan-Lluka LJ
J Neurochem; 2005 Sep; 94(6):1620-30. PubMed ID: 16092934
[TBL] [Abstract][Full Text] [Related]
7. The N-terminus of the norepinephrine transporter regulates the magnitude and selectivity of the transporter-associated leak current.
Binda F; Lute BJ; Dipace C; Blakely RD; Galli A
Neuropharmacology; 2006 Mar; 50(3):354-61. PubMed ID: 16289633
[TBL] [Abstract][Full Text] [Related]
8. Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition.
Melikian HE; Ramamoorthy S; Tate CG; Blakely RD
Mol Pharmacol; 1996 Aug; 50(2):266-76. PubMed ID: 8700133
[TBL] [Abstract][Full Text] [Related]
9. Determinants within the C-terminus of the human norepinephrine transporter dictate transporter trafficking, stability, and activity.
Bauman PA; Blakely RD
Arch Biochem Biophys; 2002 Aug; 404(1):80-91. PubMed ID: 12127072
[TBL] [Abstract][Full Text] [Related]
10. Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins.
Apparsundaram S; Schroeter S; Giovanetti E; Blakely RD
J Pharmacol Exp Ther; 1998 Nov; 287(2):744-51. PubMed ID: 9808705
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity.
Reith ME; Wang LC; Dutta AK
J Neurosci Methods; 2005 Apr; 143(1):87-94. PubMed ID: 15763140
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the functional roles of the MELAL and GQXXRXG motifs of the human noradrenaline transporter using cysteine mutants.
Sucic S; Bryan-Lluka LJ
Eur J Pharmacol; 2007 Feb; 556(1-3):27-35. PubMed ID: 17141753
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine residue 271 of the norepinephrine transporter is an important determinant of its pharmacology.
Paczkowski FA; Bryan-Lluka LJ
Brain Res Mol Brain Res; 2001 Dec; 97(1):32-42. PubMed ID: 11744160
[TBL] [Abstract][Full Text] [Related]
14. Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusers.
Mash DC; Ouyang Q; Qin Y; Pablo J
J Neurosci Methods; 2005 Apr; 143(1):79-85. PubMed ID: 15763139
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of transport function and desipramine binding at the human noradrenaline transporter by N-ethylmaleimide and protection by substrate analogs.
Foley KF; Cozzi NV
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):457-61. PubMed ID: 12070759
[TBL] [Abstract][Full Text] [Related]
16. Amphetamine induces a calcium/calmodulin-dependent protein kinase II-dependent reduction in norepinephrine transporter surface expression linked to changes in syntaxin 1A/transporter complexes.
Dipace C; Sung U; Binda F; Blakely RD; Galli A
Mol Pharmacol; 2007 Jan; 71(1):230-9. PubMed ID: 17032905
[TBL] [Abstract][Full Text] [Related]
17. Functional significance of a highly conserved glutamate residue of the human noradrenaline transporter.
Sucic S; Paczkowski FA; Runkel F; Bönisch H; Bryan-Lluka LJ
J Neurochem; 2002 Apr; 81(2):344-54. PubMed ID: 12064482
[TBL] [Abstract][Full Text] [Related]
18. A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters.
Hahn MK; Robertson D; Blakely RD
J Neurosci; 2003 Jun; 23(11):4470-8. PubMed ID: 12805287
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological properties of naturally occurring variants of the human norepinephrine transporter.
Runkel F; Brüss M; Nöthen MM; Stöber G; Propping P; Bönisch H
Pharmacogenetics; 2000 Jul; 10(5):397-405. PubMed ID: 10898109
[TBL] [Abstract][Full Text] [Related]
20. Role of proline residues in the expression and function of the human noradrenaline transporter.
Paczkowski FA; Bryan-Lluka LJ
J Neurochem; 2004 Jan; 88(1):203-11. PubMed ID: 14675164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
